A recent study has found that exercise and the common over-the-counter drug ibuprofen may help alleviate the cognitive effects of cancer therapy, commonly known as 'chemo brain'. This condition, characterized by memory loss and difficulty concentrating, affects a majority of cancer patients undergoing treatments like chemotherapy and radiation.
The research suggests that these interventions could combat the deterioration in cognitive function that many patients experience. As the study progresses through clinical trials, it offers hope for managing side effects that significantly impact quality of life.
Meanwhile, companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are developing novel cancer treatments that aim to reduce such side effects. Their R&D programs focus on therapies that are less detrimental to cognitive health.
The findings underscore the potential of lifestyle and pharmacological approaches to improve patient outcomes during cancer treatment. Further research is needed to confirm these benefits and establish guidelines for integrating exercise and ibuprofen into standard care.
